Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 48:939-947, doi:10.1016/j.jacc.2006.04.085
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Online Appendix
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Westerhout, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Westerhout, C. M.

Short- and Long-Term Risk Stratification in Acute Coronary Syndromes

The Added Value of Quantitative ST-Segment Depression and Multiple Biomarkers

Cynthia M. Westerhout, MSc*,{dagger},*, Yuling Fu, MD*, Michael S. Lauer, MD, FACC{ddagger}, Stefan James, MD, PhD§, Paul W. Armstrong, MD, FACC*, Eyad Al-Hattab, MD{ddagger}, Robert M. Califf, MD, FACC||,2, Maarten L. Simoons, MD, FACC{dagger}, Lars Wallentin, MD, PhD, FACC§,1, Eric Boersma, PhD{dagger} on behalf of the GUSTO-IV ACS Trial Investigators

* University of Alberta, Edmonton, Canada
{dagger} Erasmus Medical Center, Rotterdam, the Netherlands
{ddagger} Cleveland Clinic Foundation, Cleveland, Ohio
§ University of Uppsala, Uppsala, Sweden
|| Duke Clinical Research Institute, Durham, North Carolina


Figure 1
View larger version (14K):

[in a new window]
 
Figure 1 Relative contribution of significant, independent factors to the prediction of 30-day death, 30-day death/myocardial infarction (MI), and 1-year death. Creat. Cl. = creatinine clearance; CRP = C-reactive protein; Curr. Smok. = current smoker; HR = heart rate; Hx Ang = history of angina pectoris; Hx CABG = history of coronary artery bypass graft; Hx CHF = history of congestive heart failure; Hx MI = history of MI; Hx lipidRx = history of hyperlipidemic therapy; Hx PCI = history of percutaneous coronary intervention; Hx strk = history of stroke; NT-proBNP = N-terminal pro-brain natriuretic peptide; ST-dep = ST-segment depression; TnT = troponin T; Wgt = weight.

 

Figure 2
View larger version (7K):

[in a new window]
 
Figure 2 Calibration of risk models: (A) 30-day death; (B) 30-day death/myocardial infarction (MI); (C) 1-year death. Dots represent deciles of predicted risk; the solid line represents perfect calibration.

 

Figure 3
View larger version (11K):

[in a new window]
 
Figure 3 Increase in adjusted C-index as biomarkers and quantitative ST-segment depression are added to the models predicting (A) 30-day (open dots) and 1-year death (closed dots) and (B) 30-day death or MI (closed diamonds). Abbreviations as in Figure 1.

 

Figure 4
View larger version (18K):

[in a new window]
 
Figure 4 Simplified risk score and nomogram to estimate risk of mortality at 30 days (open dots) and 1 year (closed dots) and of death or myocardial infarction (MI) at 30 days (solid x’s).

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement